Company / Working Capital per Share
ENDONOVO THERAPEUTICS, INC. Working Capital per Share History
FY2014-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$0.45
FY2022
5-year range
-$54.66 / -$0.05
FY2018-FY2022
Trend
+37.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has increased for 3 consecutive years, from $-54.66 in FY2019 to $-0.45 in FY2022.
Based on SEC 10-K filings.
-0.45 in FY2022.
Improved from $-14.11 to $-0.45 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENDONOVO THERAPEUTICS, INC.'s working capital per share has grown for 3 consecutive years.
- In FY2022, working capital per share increased 37.6% year-over-year.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$0.45 | +37.6% |
| FY2021 | -$0.72 | +94.9% |
| FY2020 | -$14.11 | +74.2% |
| FY2019 | -$54.66 | -114652.9% |
| FY2018 | -$0.05 | +40.7% |
| FY2016 | -$0.08 | +28.2% |
| FY2015 | -$0.11 | +98.0% |
| FY2014 | -$5.47 | - |
| FY2011 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026